Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
881 to 900 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| R01CA232574 | Treatment-Induced Phenotypic Reprogramming in Prostate Cancer | 1 | 2023 |
| R01CA233490 | Genetic and Epigenetic Biomarkers for B-cell Lymphoma | 1 | 2023 |
| R01CA233512 | Functional reprogramming of tumor-MDSC through antibody-based therapies targeting Notch ligands | 1 | 2023 |
| R01CA233794 | Reverse-engineering precision liver cancer chemoprevention | 1 | 2023 |
| R01CA233975 | A Genomic Framework for Molecular Risk Prediction & Individualized Lymphoma Therapy | 1 | 2023 |
| R01CA234553 | Role of the microenvironment in ovarian cancer metastasis | 1 | 2023 |
| R01CA237586 | TARGETING HISTONE DEMETHYLASE KDM5B IN BREAST CANCER | 1 | 2023 |
| R01CA238163 | Investigating T Cell Egress via Lymphatic Vessels in Melanoma | 1 | 2023 |
| R01CA239255 | Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion | 1 | 2023 |
| R01CA240434 | Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma | 1 | 2023 |
| R01CA240472 | Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma | 1 | 2023 |
| R01CA240526 | INVESTIGATING TUMOR INITIATION AND INVASION IN PREMALIGNANT BREAST CANCER WITH SPATIAL SINGLE CELL GENOMICS | 1 | 2023 |
| R01DE023685 | PI3K Pathway Mutations in Head and Neck Cancer | 1 | 2023 |
| R01DE028289 | Targeting STAT3 to enhance anti-tumor immunity | 1 | 2023 |
| R01DE030493 | Investigating the prognostic role of intrinsic immune evasion mechanisms in HNSCC | 1 | 2023 |
| R01DK121969 | Loss of Bladder Control Following Recurrent Infections | 1 | 2023 |
| R01DK126478 | Impact of Inflammation on Adult Prostate Stem Cells | 1 | 2023 |
| R01GM129076 | The role of the free energy landscape in Parkin's function and dysfunction in health and disease | 1 | 2023 |
| R01GM132100 | Engineering selective inhibition of metalloproteinases by tissue inhibitors of metalloproteinases (R01 GM132100 RESUB - *TIMPs) | 1 | 2023 |
| R01GM135337 | Role of very long chain fatty acids in protein quality control and membrane homeostasis | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=45